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Abstract
Kinesin proteins are critical for various cellular functions such as intracellular transport and cell division, and many members
of the family have been linked to monogenic disorders and cancer. We report eight individuals with intellectual disability
and microcephaly from four unrelated families with parental consanguinity. In the affected individuals of each family,
homozygosity for likely pathogenic variants in KIF14 were detected; two loss-of-function (p.Asn83Ilefs*3 and p.Ser1478fs),
and two missense substitutions (p.Ser841Phe and p.Gly459Arg). KIF14 is a mitotic motor protein that is required for spindle
localization of the mitotic citron rho-interacting kinase, CIT, also mutated in microcephaly. Our results demonstrate the
involvement of KIF14 in development and reveal a wide phenotypic variability ranging from fetal lethality to moderate
developmental delay and microcephaly.
Introduction
KIF14 (Kinesin family 14, MIM: 611279), encodes a
member of the kinesin-3 superfamily of microtubule motor
proteins which act predominantly as “plus-end” directed
molecular motors that generate force and movement across
microtubules [1, 2]. Kinesin proteins were ﬁrst identiﬁed in
1985 [3, 4] and their action is critical for numerous cellular
functions such as intracellular transport and cell division [5,
6]. Fourteen members of the kinesin family have so far been
linked with various degrees of evidence to monogenic
disorders with several modes of inheritance, and a wide
phenotypic spectrum affecting several organ systems
(Table 1). KIF14 has a major role in cytokinesis and has
been extensively studied in cancer [7]. Somatic variants
have classiﬁed KIF14 as an oncogene [8]; it has been
suggested that its overexpression could be used as a prog-
nostic marker in various tumor types [9, 10] and is a
potential target for cancer treatment [11, 12].
Numerous studies have relied on the power of con-
sanguineous families to identify causes of recessive disease
by applying homozygosity mapping strategies, or by ﬁl-
tering genome-wide data sets for the restricted set of
homozygous deleterious variants. The accessibility of
exome and genome variomes capturing extant genetic var-
iation in special populations, mostly from Asia and the
Middle East, has allowed prioritization of variants that are
rare at the population level, and thus more likely to con-
tribute to disease [13].
As part of an effort to identify new recessive syndromes
in consanguineous pedigrees, we present here four families
with intellectual disability/developmental delay (ID/DD),
small head size, and a variety of additional clinical
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symptoms. Interestingly, a mouse model, laggard (lag),
carrying a spontaneous variant [14] has been shown to have
a similar phenotype with growth retardation, brain size
reduction, severe hypomyelination of the central nervous
system including the optic nerve, and motor impairment.
Lag/lag mice die before weaning and targeted knockouts
have conﬁrmed KIF14 as the causative gene. In addition, a
single family was described by Filges et al. [15]. with two
fetuses showing identical severe intrauterine growth
restriction (IUGR), microcephaly, brain malformations,
renal cystic dysplasia/agenesis, and other genitourinary
malformations, that displayed biallelic deleterious variants
in KIF14. An autosomal recessive disease with lethal fetal
ciliopathy phenotype was proposed.
Materials and methods
Patient description
Family 1
Family 1 (Fig. 1) is of Egyptian origin and the patients were
offspring of ﬁrst cousins, the father being himself an off-
spring of a consanguineous marriage. The older affected girl
was born after a non-remarkable 40-week pregnancy. Birth
measurements are reported as average. At her ﬁrst clinical
exam at 12 years of age, she weighted 18 kg (−2.6 SD), the
head circumference was 52 cm (−1.3 SD), and height was
125 cm (−4 SD). She sat at 4 years, has never walked and
while at birth she was described as hypotonic, at the time of
her clinical examination her muscle tone was spastic with
brisk reﬂexes. She has never spoken and is suffering from
severe ID. G-band karyotype (46,XX) was normal as well
as the rest of her work-up: brain CT, metabolic screening,
thyroid function tests, hearing test, and complete eye
evaluation.
The younger affected sister was also born after
an uneventful full-term pregnancy, birth measurements are
not available. At 3 years of age she weighed 10.5 kg
(−2 SD), had a height of 82 cm (−2.9 SD) and a head cir-
cumference of 47 cm (−1.6 SD). According to the parents,
she has an identical clinical course to that of her older
sister with ID/DD. Brain CT, thyroid/metabolic screening,
and hearing/vision gave unremarkable results, like her sis-
ter. Both sisters had small mouth, wide and sparse eye-
brows, and strabismus. The older sister also has a
characteristic foot morphology with big ﬁrst toe, sandal gap,
external deviation of the 2nd and 3rd toes, the latter being
overlapped by the 4th toe. The younger sister has no feet
anomalies.
Family 2
Family 2 is of Turkish origin, and the parents are ﬁrst
cousins. Two out of ﬁve siblings are affected with severe
ID, microcephaly, complete blindness with optic nerve
hypoplasia, and micropthalmia. The proband in this family
Table 1 KIF genes known to
cause or confer susceptibility to
monogenic disorders
Genes MIM Phenotype Inheritance
KIF1A 601255 Mental retardation, autosomal dominant 9; Neuropathy, hereditary
sensory, type IIC; Spastic paraplegia 30, autosomal recessive
AD or AR
KIF1B 605995 Neuroblastoma, susceptibility to; Pheochromocytoma;?
Charcot–Marie–Tooth disease, type 2A1
AD
KIF1BP 609367 Goldberg-Shprintzen megacolon syndrome AR
KIF1C 603060 Spastic ataxia 2, autosomal recessive AR
KIF2A 602591 Cortical dysplasia, complex, with other brain malformations 3 AD
KIF4A 300521 ?Mental retardation, X-linked 100 XL
KIF5A 602821 Spastic paraplegia 10, autosomal dominant AD
KIF5C 604593 Cortical dysplasia, complex, with other brain malformations 2 AD
KIF7 611254 ?Hydrolethalus syndrome 2; Acrocallosal syndrome; Joubert
syndrome 12
AR
KIF10
(CENPE)
117143 ?Microcephaly 13, primary, autosomal recessive AR
KIF11 148760 Microcephaly with or without chorioretinopathy, lymphedema, or
mental retardation
AD
KIF21A 608283 Fibrosis of extraocular muscles, congenital 1; Fibrosis of extraocular
muscles, congenital 3B
AD
KIF22 603213 Spondyloepimetaphyseal dysplasia with joint laxity, type 2 AD
AD autosomal dominant, AR autosomal recessive, XL X-linked
“?” denotes a suspected phenotype, usually only one family reported to date
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was born in Turkey after an uneventful pregnancy and had a
normal birth weight. The parents discovered his blindness at
3 weeks of age. He was evaluated the Pediatric Department
in Oslo at 7 years of age when the family arrived in Nor-
way; he was blind with bilateral microphthalmia, had severe
ID/DD and no language, severe microcephaly, could stand
and walk with support. He had been exclusively milk-fed
and was cachectic. Head CT was normal at 7 years of age,
and MRI at 8 years of age showed reduced brain volume,
large basal cisterns, and optic atrophy. A pathological EEG
pattern during sleep was documented, with frequent sharp
focal activity, and occasional spike and wave, left temporal-
occipital region, but no seizures. He had normal reﬂexes on
neurological exam. At 14 years of age, his OFC was 48 cm,
length 145 cm (−3.4 SD), and weight was only 28 kg. At 23
years of age, his OFC was still the same (−5.1 SD), his
length 157 cm (−3.7 SD), and weight 47 kg. He has bilat-
eral microphthalmos and extreme microcephaly, otherwise
normal facial features. He has severe behavioral problems
with aggressive outbursts and violence against caregivers,
that are often triggered by certain sounds or noise, and he
has self-stimulating and self-destructive behavior. He is
autistic, has tactile aversion and is sound sensitive, but
enjoys classical music and is surprisingly well oriented in
the examination room.
His younger, affected sister (Fig. 1, individual IV:6) was
born at term with Apgar 9/9, birth weight 3450 g, birth
length 49 cm, and had OFC 32 cm (−2.6 SD). X-rays
excluded craniosynostosis and a later skeletal survey, at 7
years of age, did not reveal any skeletal abnormalities. At 7
years of age, she had severe ID and autistic features, her
OFC was 42 cm (−7.3 SD), height 102 cm (−4.2 SD). She
had microphthalmia and was blind. At 20 years of age, her
OFC was 47 cm (−5.6 SD), height 144 cm (−3.8 SD), small
hands and feet (shoe size: Eur 34/US 2). She has aggressive
outbursts, but milder than her brother. She has no speech,
but can understand some phrases. She plays a couple of
simple melodies with one ﬁnger on the piano, and is able to
sing along reaching the correct tone in the melody. She
easily gets confused and anxious, and refuses to be held for
medical investigation.
Family 3
The proband presented at age 3 years with ID/DD, attention
deﬁcit hyperactivity disorder (ADHD), strabismus and
microcephaly. She was the product of a ﬁrst-cousin con-
sanguineous marriage from Egyptian parents residing in
Cairo. She displayed typical gross and ﬁne motor skills but
absent language skills. Social skills were delayed by 1.5
Fig. 1 Family pedigrees, genotype, and KIF14 variants. a Pedigrees of
four families affected by KIF1 variants showing segregation of the
altered alleles and chromatograms of these variants-altered alleles
shown by “+” and wild-type allele shown by “−”. b, c Schematic
overview of the KIF14 gene (top) and protein (bottom) and location of
the identiﬁed variants in the current study(black) and two compound
variants from previous study (gray)
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years. Apart from one episode of seizures at 15 days of life
during an intercurrent fever, there were no other neurolo-
gical or general physical deformities. Head circumference at
5 years of age was 41.5 cm (−6.4 SD), and was reported to
be reduced at birth, but measurements were not available.
Brain MRI has shown a predominantly frontal lobe sim-
pliﬁed gyral pattern without other major structural anoma-
lies noted. The second child from this family was noted to
be microcephalic at birth with head circumference 30 cm,
and showed a similar uneventful clinical course marked by
delayed development. Brain MRI at 1 year of age showed
simpliﬁed gyral pattern, frontal cerebral atrophy, cerebellar
hypoplasia, and partial agenesis of the corpus callosum.
Head circumference at 2 8/12 years of age was 39.5 cm
(−5.6 SD).
Family 4
In a consanguineous family originating from Iran,
two pregnancies of a ﬁrst-cousin couple were interrupted
due to severe fetal malformations. Both fetuses were
male and the ﬁrst was aborted at 15 weeks due to
severe microcephaly detected on ultrasound. Further
examination demonstrated narrowing of the cranial
sutures suggestive of craniosynostosis, but no other
anomalies were detected. The second pregnancy was ter-
minated at 17 weeks after detection of severe microcephaly.
General growth was normal with an estimated weight of
176 g (40th centile), and there were no brain or cardiac
malformations.
The successful gathering of information of affected
individuals with similar phenotypes and likely disease-
causing variants in the candidate causative gene was pos-
sible due to GeneMatcher (https://genematcher.org/) [16].
Variant detection
Family 1
The laboratory and bioinformatics analysis for the variant
identiﬁcation was performed as previously described [17].
The study was approved by the Bioethics Committee of the
University Hospitals of Geneva (Protocol number: CER 11-
036).
Family 2
Whole-exome sequencing (WES) was performed on the
proband at the Human Genome sequencing center (HGSC)
at Baylor College of Medicine through the Baylor-Hopkins
Center for Mendelian Genomics initiative. Using 1ug of
DNA an Illumina paired-end pre-capture library was con-
structed as described in the BCM-HGSC Illumina Barcoded
Paired-End Capture Library Preparation protocol. Pre-
capture libraries were pooled into 4-plex library pools and
then hybridized in solution to the HGSC-designed
Core capture reagent [18] (52 Mb, NimbleGen) or 6-plex
library pools used the custom VCRome 2.1 capture
reagent1 (42Mb, NimbleGen). With a sequencing yield of
9.1 Gb, the sample achieved 91% of the targeted exome
bases covered to a depth of 20× or greater. Illumina
sequence analysis was performed using the HGSC Mercury
analysis pipeline [19, 20] (https://www.hgsc.bcm.edu/
software/mercury). The clinical SNP array of the proband,
parents, and two unaffected siblings was performed with
Affymetrix Genome-Wide Human SNP Array 6.0 accord-
ing to manufacturer’s protocol (Thermo Fisher Scientiﬁc
Inc., CA, USA).
Research protocols were approved via institutional
research boards (H-29697- Genome Sequencing to Eluci-
date the Causes and Mechanisms of Mendelian Genetic
Disorders) and regional ethics committee in keeping with
national guidelines, and the molecular analyses in the
family were performed in accordance with the Norwegian
National Biotechnology Act. All legal guardians, parents,
and close family members provided written informed con-
sent for study participation for themselves and their affected
relatives as well as for publication of clinical information,
molecular ﬁndings, and photographs.
Family 3
WES was performed on the proband, with >96% of the
exome covered at >12×. GATK best practices pipeline was
used for SNP and INDEL variant identiﬁcation and XHMM
was used for structural variant detection. Homozygous
variant prioritization included MAF< 0.001 in a cohort of
over 3000 Egyptians, and GERP score> 4.0. The study was
approved by the Institutional Review Board (IRB) of UC
San Diego (140028). Written informed consent was
obtained from all participants.
Family 4
WES was performed on the DNA from the aborted second
fetus. No DNA was available from the ﬁrst affected preg-
nancy. On the assumption that the disease follows an
autosomal recessive inheritance in the family as well as
presence of consanguinity, we prioritized the homozygous
potentially functional variants residing within the runs of
homozygosity. These variants were screened through pub-
licly available population databases and our in-house data-
base generated for frequency in human population. We
excluded synonymous variants, intronic variants (>5 bp
from exon boundaries) and common variants (minor allele
frequency, >0.001%).
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Estimating potential pathogenic variants and their
cumulative frequency in gnomAD
In gnomAD (http://gnomad.broadinstitute.org/), 860 mis-
sense and predicted LoF variants are reported in KIF14.
Potential pathogenic variants have been selected based on a
two-step approach: (i) variants with MAF higher than 0.02
and homozygous variants have been excluded, (ii) among
the remaining LoF variants and missense variants predicted
pathogenic by SIFT (http://sift.jcvi.org/) [21], PolyPhen2
(http://genetics.bwh.harvard.edu/pph2/) [22], and Muta-
tionTaster (http://www.mutationtaster.org/) [23] have been
designated as potentially pathogenic.
Results
Variant identiﬁcation
Family 1
After a combination of homozygosity mapping and exome
sequencing using CATCH [24], we identiﬁed two poten-
tially pathogenic variants, that have been conﬁrmed through
Sanger sequencing and the correct segregation in the family
was veriﬁed. The ﬁrst was in KIF14 NM_014875.2:
c.2522C>T:p.(Ser841Phe), (dbSNP142: rs139385693). The
second was in PTPRC (MIM: 151460), NM_002838.4:
c.3416C>T:p.(Ser1137Phe), (dbSNP142: rs549131091).
Both variants are present in ExAC in the African popula-
tion, the ﬁrst twice with a MAF of 0.0001924 and the
second once with a MAF of 9.705e−05. Between the two,
KIF14 was considered the main candidate since homo-
zygous or compound heterozygous pathogenic PTPRC
variants are responsible for a severe combined immunode-
ﬁciency (MIM: 608971) that presents at the ﬁrst 2–3 months
of life and that the patients of family 1 did not have.
Family 2
Clinical SNP array in this family had previously revealed
several homozygous loci in the proband, not shared by two
of the unaffected siblings. WES of the proband’s (Fig. 2,
individual F2-IV.2) sample revealed 35 homozygous var-
iants with ESP MAF less than 0.01, and 8 of them were not
seen in any in-house or publicly available variant frequency
database. Seven of these non-X-linked variants were located
at sites conserved across species, and the two most inter-
esting ones were the KIF14 variant c.246del
(NM_014875.2), and a missense variant in INPP5A:
c.920A>C (NM_005539.4). INPP5A is an enzyme
expressed in the brain and the gene is homologous to
INPP5B and to OCRL, the gene responsible for Lowe
oculocerebrorenal syndrome (OMIM#309000). Familial
study demonstrated that only KIF14 segregated correctly in
the family.
Family 3
Homozygous variants in four genes (NYNRIN, ZNF746,
PXK, and KIF14) were predicted to be pathogenic. Only
KIF14 NM_014875.2:c.1375G>A:p.(Gly459Arg) segre-
gated with the disease in both affected siblings upon Sanger
sequence conﬁrmation, and occurred within a 6Mb block of
homozygosity. This variant has not been reported in either
gnomAD or 1000 Genomes.
Family 4
The ﬁltered WES data narrowed down the variants to a
homozygous single nucleotide deletion in exon 29 of KIF14
(c.4432delA; p.(Ser1478fs)) located within a ~17.8 Mb
region of homozygosity on chrq3-q35.3. The variant was
never observed in any public variant database and it was
predicted to delete a highly conserved functionally impor-
tant C-terminal domain of the protein. The variant was
validated by Sanger sequencing and the parents and the
only healthy sibling were all heterozygous. No other
pathogenic/likely pathogenic variant were identiﬁed in the
currently known monogenic disease-causing genes in the
WES data.
The relative positions of all the identiﬁed variants are
shown in Fig. 2. All identiﬁed variants have been submitted
to LOVD (https://databases.lovd.nl) with submissions ID
00132082 to 00132085.
Fig. 2 Model of human KIF14 motor domain with Gly459’s position
on the L5 loop indicated with red color. ADP is presented with atom
and surface representation. The hydrogen bond between Gly459 and
Ser454 is indicated as cyan line
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Modeling of the missense variants
The KIF14 kinesin superfamily of microtubule-associated
molecular motor proteins have an important role in intra-
cellular transport and cell division. The motor domain of
KIF14 is in the center of the protein (aa 358–701), whereas
the «forkhead-associated» (FHA) domain that recognizes
the phosphothreonine, is located towards the C-terminal
region (aa 825–891). The two missense variants p.
Gly459Arg and p.Ser841Phe are located within the motor
domain and FHA domain, respectively. There is no full-
length structure of KIF14 available, but there are experi-
mental structures of single domains for close homologs of
human KIF14 which were used to create homology models.
The Gly459 residue is located within the KIF14 motor
domain that was modeled based on mouse KIF14 motor
domain structure (4OQZ PDB) [25], which shares 83%
sequence identity with the human motor domain. Gly459 is
located on the L5 loop, close to the ATP/ADP binding
pocket. It has a structural role in stabilizing the loop
structure, as it forms hydrogen bond with Ser454 on the
preceding alpha helix. In Fig. 2, the hydrogen bond is
indicated as cyan line. p.(Gly459Arg) variant is most
probably changing the structure of the L5 loop and may
inﬂuence the ATP/ADP binding and even microtubules
binding, as it is reported for variants in this region for other
kinesins [26].
The Ser841 residue is in the FHA domain. It was mod-
eled based on the 4EGX structure of CC1/FHA domain of
kinesin-3, with 35% of sequence identity between both
sequences. In the kinesin-3, the coiled-coil domain and
FHA domain are involved in the dimerization of kinesin and
regulation of motor function activity [27]. KIF14 domains
are organized as in kinesin-3, which might indicate a similar
role in dimerization and regulatory function of the ﬁrst
coiled-coil region and FHA domain. In our model of KIF14,
FHA domain Ser841 residue’s side chain forms a hydrogen
bond with Glu814, stabilizing the FHA domain structure
(Fig. 3). Upon change from Ser841 to Phe (c.2522C>T:p.
(Ser841Phe)), formation of this hydrogen bond is not pos-
sible and the stability of the FHA domain might be com-
promised. The change in the structure of FHA domain
occurring as a consequence of the Ser841Phe variant might
inﬂuence assumed FHA-mediated dimerization and this
way perturb the activity of the motor domain.
Potential pathogenic variants in gnomAD
There are 64 predicted LoF variants for a total of 137
alleles. There are 759 missense variants after the selection
process described, 170 of which are predicted to be
pathogenic by all three software programs for a total of 637
alleles. Combined these two groups of variants have a
cumulative MAF of 0.00279, which translates that ~1/
128,000 individuals would carry two predicted pathogenic
variants. This calculation represents a very crude estimation
as it does not consider speciﬁc population frequencies, the
possibility that two variants are in cis conﬁguration, and is
based on in silico pathogenicity prediction algorithms.
Discussion
We present four families with non-synonymous predicted
loss-of-function (LoF) homozygous variants in KIF14.
Table 2 presents a summary of the phenotypic ﬁndings in
each one of the affected individuals along with the ﬁndings
reported by FIlges et al. [15]. All patients have been iden-
tiﬁed by combining homozygosity mapping and exome
sequencing. Among the pregnancies that reached term, 5/6
patients had severe ID/DD with or without autistic features
and attention deﬁcit hyperactivity disorder (ADHD), and
the patients have either microcephaly (5/7) or occipital
frontal circumference (OFC) at the lowest normal values (1/
7) according to WHO criteria. For the majority of the
additional features described in the patients there is none
that is present in all of them leading to related but not
identical phenotypes. As such, 5 of 7 are presenting
symptoms from the ocular system, ranging from strabismus
to microphthalmia, 3 of 7 presented with hypotonia, at least
at the beginning of the life, 5 of 7 had either no speech or
speech delay, and 3 of 7 had delay in gross motor devel-
opment. Overall, 3 of 7 had short stature. There is no
apparent common facial gestalt, brain imaging showed
speciﬁc pathologic ﬁndings in 3 patients; and one patient
Fig. 3 Model of homodimeric structure of FHA domain of the human
KIF14 protein. One domain presented in coral (left-side), second one
presented in white (right-side). Side chain of residue Ser841 forming a
hydrogen bond with Glu814, stabilizing the FHA structure is shown
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had foot deformities and frequent respiratory infections. A
possible explanation of the additional features may be the
fact that all the patients come from consanguineous families
and the possibility of a second simultaneous disorder cannot
be excluded.
The patients in families 1–3 show a spectrum that seems
to be less severe than the ones reported by Filges et al. [15],
however, the affected fetuses in family 4 may closer
resemble Filges’ report, but none has overt genitourinary
signs and symptoms. In comparison with the Filges et al.
[15] report that describes a lethal fetal disorder with severe
brain growth restriction and IUGR due to frameshift variant,
our patients represent a contiunuum towards somewhat
milder phenotypes. The siblings in family 1 with a missense
variant in exon 14 have severe ID and no speech, but nor-
mal head circumference, and the siblings in family 3, also
with missense variant, had microcephaly but less severe ID.
The patients in family 2 with the early frameshift variant
have severe microcephaly with prenatal onset, as well as
complete blindness with optic nerve hypoplasia and
microphthalmia. In family 4, where the other frameshift
variant was detected, both fetuses had been terminated at
gestational age week 15th and 17th because of severe
microcephaly.
The variants detected in our patients span the entire gene
(from exon 2 to exon 29) and are both missense and pre-
dicted LoF. The small number of patients does not allow for
deﬁnitive phenotype–genotype correlations, but in the two
families with the missense variants we observe relatively
milder phenotypes. In the ﬁrst family, microcephaly is not
observed while in the third family one of the children car-
rying the KIF14 variants, despite microcephaly and brain
abnormalities, does not have severe developmental delay at
age 2½ years of age. These observations suggest that the
missense variants reported may be hypomorphs leading to
less severe phenotypes. More cases are needed to study the
potential phenotypic correlation with the KIF14 pathogenic
variants.
A knockout mouse model has also been recently pub-
lished with features similar to those described in the patients
(microcephaly, slender optic nerves, small body size) [14];
these mice develop severe ataxia, and die shortly after birth,
in contrast to the reported patients. No hypomyelination was
identiﬁed in our patients, contrary to what was described in
the mouse model.
In ExAC (http://exac.broadinstitute.org/) [28], there
seems to be no constraint on the gene, neither for the
missense (z=−1.18) nor for the LoF variants (pLI= 0).
These metrics are compatible with genes that follow auto-
somal recessive inheritance. In the GTEx portal (www.
gtexportal.org), the highest expression is seen in testis,
esophagus, and small intestine with minimal expression in
brain. On the contrary, in MGI (http://www.informatics.jax.
org) expression is observed in the eye before and after birth
(the eye is not interrogated in GTEx).
The KIF family of genes have already been linked to
several monogenic disorders the majority of which are
characterized by intellectual disability or other neurologic
symptoms with various other systems affected. (Table 1).
Filges et al. [15] suggested the human autosomal recessive
KIF14 related disease to be a fetal lethal ciliopathy. Other
kinesins may cause ciliopathy, such as Joubert syndrome in
KIF7 related disease (OMIM#200990) [29]. Ciliar intra-
ﬂagellar transport cargoes are transported along axonemal
microtubules by kinesin and dynein motors; however, the
link between ciliopathies and kinesin proteins is not yet
clearly clariﬁed for all kinesin proteins [30].
For KIF14, its function as mitotic motor protein at the
spindle poles may be the cause of the neurological pheno-
types observed. There are also KIF genes (KIF21A and
KIF22) that are not causing neurologic phenotypes. There
seems to be no preferred mode of inheritance as autosomal
dominant, recessive, and X-linked modes are documented.
Primary microcephaly (MCPH) is most often caused by
biallelic LoF variants in a host of genes encoding proteins
functioning in cytokinesis. Most MCPH proteins show
predominant localization to the centrosome and spindle pole
during the cytokinesis stage of cell division [31], and
mutant cells show defective spindle orientation, and
reduced centrosome integrity, and reduced ﬁdelity of
chromosome distribution to the daughter cells. KIF14 is a
mitotic motor protein that is required for spindle localiza-
tion of the citron rho-interacting kinase, CIT, also mutated
in microcephaly (OMIM#617090). At least two mechan-
isms have been proposed for the reduced number of neurons
that results from these variants: (1) Depletion of stem cell
progenitors due to a shift in balance toward asymmetric cell
division and (2) Genotoxic stress due to slowed or inaccu-
rate chromosome segregation [32]. The latter was proven to
be relevant in several microcephaly models, as removal of
p53, which allows cell division to continue in the presence
of genotoxic stress, rescued the severe neuronal loss [33].
In addition to the focus of MCPH proteins at the spindle
poles, there is attention now on their role at the midbody,
which is a specialized protein complex regulating the ﬁnal
separation of the two daughter cells at the completion of
cytokinesis [34]. KIF14 now joins ASPM and CIT as MCPH
genes whose proteins localize to the midbody function.
Importantly, KIF14 is required for CIT localization to the
midbody. Moreover, variants affecting the protein’s func-
tion in either result in the highly speciﬁc ﬁnding of bi-
nucleated daughter cells, as a reﬂection of failed midbody
function [15, 35, 36]. These cells show similar vulnerability
to genotoxic stress, and increased cellular apoptosis, which
probably accounts for the severe reduction in brain size [33,
37].
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The data presented here suggest that biallelic variants
affecting the function of KIF14’s result in a wide phenotype
spectrum involving intellectual disability, microcephaly,
and short stature.
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